Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes anti-infective drugs based on its proprietary class of compounds, Ceragenins. Active against a broad range of gram positive and gram negative bacteria, these agents are being developed as anti-infective medical device coatings and as therapeutics for serious antibiotic-resistant organisms. Ceragenix Pharmaceuticals Inc. is an emerging biopharmaceutical company headquarted in Denver, Colorado. It develops prescription therapies based on a platform of proprietary surface active technologies—skin Barrier Repair Technology (BRT) and Cerageninis, a new class of broad spectrum anti-infectives...